Sanofi (SAN.PA)
Paris - Paris Delayed price. Currency in EUR
Add to watchlist
As of 10:59AM CEST. Market open.
| Previous close | 91.30 |
| Open | 91.30 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 91.20 - 91.95 |
| 52-week range | 80.60 - 104.32 |
| Volume | |
| Avg. volume | 1,387,266 |
| Market cap | 114.687B |
| Beta (5Y monthly) | 0.45 |
| PE ratio (TTM) | 25.43 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 3.76 (4.09%) |
| Ex-dividend date | 13 May 2024 |
| 1y target est | N/A |
- Insider Monkey
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript May 2, 2024 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $9.55 EPS, expectations were $10.17. Regeneron Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to […]
- Thomson Reuters StreetEvents
Q1 2024 Kymera Therapeutics Inc Earnings Call
Q1 2024 Kymera Therapeutics Inc Earnings Call
- Zacks
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
Regeneron (REGN) reports Q1 results, wherein both the top and bottom lines miss estimates due to lower Eylea sales. Shares down.
© 2024 Yahoo. All rights reserved.